These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28609734)

  • 21. Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical data.
    Kothare S; Kluger G; Sachdeo R; Williams B; Olhaye O; Perdomo C; Bibbiani F
    Seizure; 2017 Apr; 47():25-33. PubMed ID: 28284045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes and adaptive behavior in adult patients with Lennox-Gastaut syndrome.
    Cerulli Irelli E; Petrungaro A; Pastorino GMG; Mazzeo A; Morano A; Casciato S; Salati E; Operto FF; Giallonardo AT; Di Gennaro G; Di Bonaventura C
    Epilepsia Open; 2024 Oct; 9(5):1881-1890. PubMed ID: 39110111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing clobazam treatment in patients with Lennox-Gastaut syndrome.
    Isojarvi J; Gidal BE; Chung S; Wechsler RT
    Epilepsy Behav; 2018 Jan; 78():149-154. PubMed ID: 29202277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.
    Sankar R; Chez M; Pina-Garza JE; Dixon-Salazar T; Flamini JR; Hyslop A; McGoldrick P; Millichap JJ; Resnick T; Rho JM; Wolf S
    Seizure; 2023 Aug; 110():42-57. PubMed ID: 37321047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pontine and cerebral atrophy in Lennox-Gastaut syndrome.
    Newham BJ; Curwood EK; Jackson GD; Archer JS
    Epilepsy Res; 2016 Feb; 120():98-103. PubMed ID: 26808205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome.
    Montouris GD; Wheless JW; Glauser TA
    Epilepsia; 2014 Sep; 55 Suppl 4():10-20. PubMed ID: 25284033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience.
    Wheless JW; Isojarvi J; Lee D; Drummond R; Benbadis SR
    Epilepsy Behav; 2014 Dec; 41():47-52. PubMed ID: 25282105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined surgical intervention with vagus nerve stimulation following corpus callosotomy in patients with Lennox-Gastaut syndrome.
    Katagiri M; Iida K; Kagawa K; Hashizume A; Ishikawa N; Hanaya R; Arita K; Kurisu K
    Acta Neurochir (Wien); 2016 May; 158(5):1005-12. PubMed ID: 26979179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lennox-Gastaut Syndrome: A State of the Art Review.
    Mastrangelo M
    Neuropediatrics; 2017 Jun; 48(3):143-151. PubMed ID: 28346953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating Lennox-Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide.
    Gresham J; Eiland LS; Chung AM
    Neuropsychiatr Dis Treat; 2010 Oct; 6():639-45. PubMed ID: 20957124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ
    Expert Opin Pharmacother; 2019 Sep; 20(13):1563-1574. PubMed ID: 31373526
    [No Abstract]   [Full Text] [Related]  

  • 32. The refractory epilepsy screening tool for Lennox-Gastaut syndrome (REST-LGS).
    Piña-Garza JE; Boyce D; Tworek DM; Davis KA; Gatens H; Lai G; McGoldrick PE; Thomas B; Wolf SM
    Epilepsy Behav; 2019 Jan; 90():148-153. PubMed ID: 30537670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vagus nerve stimulation in patients with Lennox-Gastaut syndrome: A meta-analysis.
    Dibué M; Greco T; Spoor JKH; Tahir Z; Specchio N; Hänggi D; Steiger HJ; Kamp MA
    Acta Neurol Scand; 2021 May; 143(5):497-508. PubMed ID: 33188523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rufinamide efficacy and safety in children aged 1-4 years with Lennox-Gastaut syndrome.
    Kim SH; Kang HC; Lee JS; Kim HD
    Brain Dev; 2018 Nov; 40(10):897-903. PubMed ID: 30166208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study.
    Arzimanoglou A; Ferreira JA; Satlin A; Mendes S; Williams B; Critchley D; Schuck E; Hussein Z; Kumar D; Dhadda S; Bibbiani F
    Eur J Paediatr Neurol; 2016 May; 20(3):393-402. PubMed ID: 26805435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient and Caregiver Health State Utilities in Lennox-Gastaut Syndrome and Dravet Syndrome.
    Lo SH; Lloyd A; Marshall J; Vyas K
    Clin Ther; 2021 Nov; 43(11):1861-1876.e16. PubMed ID: 34774333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The direct cost of seizure events in severe childhood-onset epilepsies: A retrospective claims-based analysis.
    Reaven NL; Funk SE; Lyons PD; Story TJ
    Epilepsy Behav; 2019 Apr; 93():65-72. PubMed ID: 30831405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lennox-Gastaut syndrome. Management update.
    Al-Banji MH; Zahr DK; Jan MM
    Neurosciences (Riyadh); 2015 Jul; 20(3):207-12. PubMed ID: 26166587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.
    Cramer JA; Sapin C; François C
    Acta Neurol Scand; 2013 Aug; 128(2):91-9. PubMed ID: 23410109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The unchanging face of Lennox-Gastaut syndrome in adulthood.
    Reyhani A; Özkara Ç
    Epilepsy Res; 2021 May; 172():106575. PubMed ID: 33721709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.